Related Experiment Videos
Inadequate luteal phase and benign breast disease
Clinical and Experimental Obstetrics & Gynecology
|January 1, 1981
Summary
This study found lower progesterone levels in women with breast pain (mastodynia). Progesterone therapy may effectively treat mastodynia and improve breast health.
Area of Science:
- Endocrinology
- Gynecology
- Oncology
Background:
- Breast pain (mastodynia) and micronodularity are common in women.
- Hormonal imbalances, particularly in the luteal phase, are suspected contributors.
Purpose of the Study:
- To compare plasma levels of estradiol (E2) and progesterone during the luteal phase in women with and without breast conditions.
- To investigate the potential therapeutic role of progesterone in managing mastodynia.
Main Methods:
- Plasma E2 and progesterone levels were measured in the luteal phase of normally menstruating women.
- Participants included women with biphasic basal body temperature, breast micronodularity, and mastodynia, compared to disease-free controls.
Main Results:
- A statistically significant difference (p < 0.001) was observed in progesterone levels between the groups.
- Women with mastodynia exhibited lower progesterone levels compared to controls.
Conclusions:
- The findings support the hypothesis that progesterone deficiency may be linked to mastodynia.
- Progesterone supply therapy shows promise for improving mastodynia and related clinical symptoms.